Kamuwa da cutar covid-19 yana damun jama'a, saboda sabbin mutane suna kamuwa da cutar kowace rana. Ya zuwa Yuni 2, 2021, an tabbatar da kararraki 5 a Faransa, ko kuma sama da mutane 677 a cikin sa'o'i 172. Haka kuma, tun bayan bullar cutar, masana kimiyya a duniya suna neman hanya don kare al'umma daga wannan sabon coronavirus, ta hanyar rigakafi. Ina binciken yake? Menene ci gaba da sakamakon? Mutane nawa ne aka yi wa rigakafin Covid-19 a Faransa? Menene illolin ? 

Kamuwa da cuta na Covid-19 da allurar rigakafi a Faransa

Mutane nawa ne aka yi wa allurar zuwa yau?

Yana da mahimmanci don bambanta adadin mutanen da suka karɓa kashi na farko na rigakafin cutar Covid-19 na alurar riga kafi, wanda ya karba allurai biyu na rigakafin mRNA daga Pfizer / BioNtech ko Moderna ko maganin AstraZeneca, yanzu Vaxzevria. 

Ya zuwa ranar 2 ga watan Yuni, a cewar ma’aikatar lafiya. 26 176 709 mutane sun karɓi aƙalla kashi ɗaya na rigakafin Covid-19, wanda ke wakiltar 39,1% na yawan jama'a. Bugu da kari, 11 220 050 mutane sun sami allura ta biyu, ko 16,7% na yawan jama'a. A matsayin tunatarwa, an fara kamfen ɗin rigakafin ne a ranar 27 ga Disamba, 2020 a Faransa. 

An ba da izinin allurar rigakafin mRNA guda biyu a Faransa, ɗaya daga Pfizer, tun daga Disamba 24 da na Modern, tun daga Janairu 8. Ga waɗannan rigakafin mRNA, ana buƙatar allurai biyu don kariya daga Covid-19. Tun daga Fabrairu 2, da An ba da izinin rigakafin Vaxzevria (AstraZeneca) a Faransa. Don yin rigakafi, kuna buƙatar allura biyu. Za a iya yin allurar rigakafin gabaɗayan jama'a nan da Agusta 31, 2021, a cewar Ministan Lafiya, Olivier Véran. Tun daga Afrilu 24, da rigakafin Janssen Johnson & Johnson ana gudanar da shi a cikin kantin magani.

Ga adadin mutanen da aka yi musu cikakken rigakafin, ya danganta da yankin, daga Yuni 2, 2021:

Wanene yanzu za a iya yi wa rigakafin Covid-19?

Gwamnati na bin shawarwarin Haute Autorité de Santé. Yanzu ana iya yin allurar rigakafin coronavirus:

• mutane masu shekaru 55 zuwa sama (ciki har da mazauna a gidajen kulawa);
• mutane masu rauni masu shekaru 18 zuwa sama kuma suna cikin haɗarin haɗari mai tsanani (ciwon daji, cututtukan koda, dashen gabobin jiki, cututtukan da ba kasafai ba, trisomy 21, cystic fibrosis, da sauransu);
• mutane masu shekaru 18 da haihuwa tare da ciwon haɗin gwiwa;
• mutanen da ke da nakasa a cibiyoyin liyafar na musamman;
• mata masu ciki daga cikin uku na biyu na ciki;
• dangin mutanen da ba su da rigakafi;
• masu sana'a na kiwon lafiya da masu sana'a a cikin sassan medico-social (ciki har da masu kula da motar asibiti), masu taimakawa gida da ke aiki tare da tsofaffi masu rauni da nakasassu, ma'aikatan motar asibiti, masu kashe gobara da likitocin dabbobi.

Tun daga ranar 10 ga Mayu, duk mutanen da suka haura shekaru 50 za a iya yi musu rigakafin Covid-19. Hakanan, tun daga ranar 31 ga Mayu, duk masu aikin sa kai na Faransa za su iya samun rigakafin rigakafin cutar, " babu iyaka shekaru ".

Yadda ake yin allurar?

Ana yin allurar rigakafin cutar ta Covid-19 ta alƙawura kawai kuma bisa ga fifikon mutane, wanda tsarin dabarun rigakafin ya bayyana akan shawarwarin Babban Hukumar Lafiya. Bugu da ƙari, ana aiwatar da shi bisa ga isar da alluran rigakafin, wanda shine dalilin da ya sa ana iya lura da bambance-bambance dangane da yankuna. Akwai hanyoyi da yawa don samun damar alƙawari don yin rigakafin: 

• tuntuɓi likitan ku ko likitan magunguna;
• ta hanyar dandalin Doctolib (alƙawari tare da likita), Covid-Pharma (alƙawari tare da likitan magunguna), Covidliste, Covid Anti-Gaspi, ViteMaDose;
• samun bayanan gida daga zauren gari, likitan ku ko likitan magunguna;
• je zuwa gidan yanar gizon sante.fr don samun bayanan tuntuɓar cibiyar rigakafin da ke kusa da gidanku;
• yi amfani da dandamali daban-daban, kamar Covidliste, vitemadose ko Covidantigaspi;
• tuntuɓi lambar kyauta ta ƙasa a 0800 009 110 (a buɗe kowace rana daga 6 na safe zuwa 22 na yamma) domin a kai shi cibiyar da ke kusa da gida;
• a cikin kamfanoni, likitocin sana'a suna da zaɓi na yin alurar riga kafi ga ma'aikatan sa kai fiye da shekaru 55 kuma suna fama da cututtuka.

Wadanne ƙwararru ne za su iya ba da allurar rigakafin Covid-19?

A cikin wani ra'ayi da Haute Autorité de Santé ya bayar a ranar 26 ga Maris, jerin ƙwararrun kiwon lafiya sun ba da izini don yin allurar rigakafi yana faɗaɗa. Za a iya yin allurar rigakafin Covid:

• masu aikin harhada magunguna da ke aiki a cikin kantin magani don amfanin cikin gida, a cikin dakin gwaje-gwaje na nazarin halittun likitanci;
• masu harhada magunguna suna ba da rahoto ga ayyukan kashe gobara da ceto da kuma bataliyar kashe gobara ta Marseille;
• masu fasahar rediyon likitanci;
• masu fasahar dakin gwaje-gwaje;
• daliban likitanci:
• na shekara ta biyu na farkon sake zagayowar (FGSM2), dangane da sun kammala aikin jinya a baya,
• a sake zagayowar na biyu a fannin likitanci, odontology, kantin magani da maieutics kuma a zagaye na uku a fannin likitanci, odontology da kantin magani,
• a shekara ta biyu da ta uku kula da jinya;
• likitocin dabbobi.

Kula da rigakafin rigakafi a Faransa

ANSM (Hukumar Tsaro ta Magunguna ta Ƙasa) tana buga rahoton mako-mako kan yuwuwar illolin alluran rigakafi Covid-19 a Faransa.

A cikin rahotonta, ANSM ya nuna cewa " Kwamitin ya sake tabbatar da faruwar wannan hatsarin thrombotic wanda ba kasafai yake faruwa ba wanda za'a iya danganta shi da thrombocytopenia ko rikicewar coagulation a cikin mutanen da aka yi wa allurar rigakafin AstraZeneca. “. Koyaya, ma'aunin haɗari / fa'ida ya kasance tabbatacce. Bugu da kari, Hukumar Kula da Magunguna ta Turai ta sanar a ranar 7 ga Afrilu, yayin wani taron manema labarai a Amsterdam, cewa zubar da jini yanzu ya kasance daya daga cikin illolin da ba kasafai ake samu ba na rigakafin AstraZeneca. Duk da haka, ba a gano abubuwan haɗari ba har yau. Har ila yau, ana kula da sigina guda biyu, kamar yadda aka gano sababbin lokuta na ciwon fuska da kuma m polyradiculoneuropathy.

A cikin rahoton na Maris 22, kwamitin ya ba da sanarwar, don rigakafin Pfizer's Comirnaty, lokuta 127 " an bayar da rahoton abubuwan da ke faruwa na zuciya da jijiyoyin jini da thromboembolic "Amma" Babu wata shaida da za ta goyi bayan rawar da allurar ke takawa a cikin faruwar waɗannan cututtuka. “. Dangane da allurar Moderna, Hukumar ta bayyana wasu ƴan lokuta na cutar hawan jini, arrhythmia da shingles. Abubuwa uku” thromboembolic abubuwan da suka faru An ba da rahoto tare da rigakafin Moderna kuma an bincika, amma ba a sami hanyar haɗi ba.

Yawancin ƙasashen Turai, gami da Faransa, sun dakatar da ɗan lokaci kuma ta hanyar " ka'idar taka tsantsan »Amfani Alurar AstraZeneca, bin bayyanar da yawa lokuta masu tsanani na rashin jini, kamar thrombosis. Wasu 'yan lokuta na abubuwan da suka faru na thromboembolic sun faru a Faransa, fiye da injections miliyan kuma an bincikar su ta Hukumar Magunguna. Ta k'arashe da cewa " fa'ida / ma'aunin haɗari na rigakafin AstraZeneca a cikin rigakafin Covid-19 yana da inganci ”Kuma” allurar ba ta da alaƙa da ƙarin haɗarin guda ɗaya na ɗigon jini ". Koyaya, " yuwuwar hanyar haɗin gwiwa tare da nau'ikan guda biyu da ba kasafai ba na ƙumburi na jini (wanda aka rarraba ta intravascular coagulation (DIC) da thrombosis sinus thrombosis na cerebral venous) waɗanda ke da alaƙa da ƙarancin platelet ɗin jini ba za a iya kawar da su ba a wannan matakin. ".

An ba da izinin yin rigakafi a Faransa 

Shugaban kasar ya ambaci dabarun rigakafin ga Faransa. Yana son shirya wani gagarumin gangamin rigakafin cutar, wanda aka fara a ranar 27 ga watan Disamba. A cewar shugaban kasar, kayayyaki suna da tsaro. Turai ta riga ta ba da umarnin allurai biliyan 1,5 daga dakunan gwaje-gwaje 6 (Pfizer, Moderna, Sanofi, CureVac, AstraZeneca da Johnson & Johnson), wanda 15% za a keɓe ga Faransanci. Dole ne Hukumar Magunguna da Haute Autorité de Santé su tabbatar da gwajin asibiti da farko. Bugu da ƙari, kwamitin kimiyya da kuma "gamayya na 'yan ƙasa»An ƙirƙiri don sa ido kan allurar rigakafi a Faransa.

A yau, manufar gwamnati a fili take: Dole ne a yi wa Faransawa miliyan 20 allurar a tsakiyar watan Mayu da miliyan 30 a tsakiyar watan Yuni. Yarda da wannan jadawalin rigakafin zai iya ba wa duk masu aikin sa kai na Faransa da suka haura shekaru 18 damar yin allurar a ƙarshen bazara. Don yin wannan, gwamnati ta samar da hanyoyi kamar:

• bude cibiyoyin rigakafi guda 1 kan Covid-700, don ba da allurar rigakafin Pfizer / BioNtech ko Moderna ga mutanen da suka wuce shekaru 19;
• tattara ƙwararrun masana kiwon lafiya 250 don yin allurar Vaxzevria (AstraZeneca) da Johnson & Johnson;
• gangamin kira da lamba ta musamman ga mutane sama da 75 waɗanda har yanzu ba su sami damar yin allurar rigakafin Covid-19 ba.

• Pfizer / BioNtech's Comirnaty rigakafin

A ranar 10 ga Nuwamba, dakin gwaje-gwaje na Amurka Pfizer ya ba da sanarwar cewa binciken kan rigakafin ya nuna " inganci fiye da 90 %”. Masana kimiyya sun dauki sama da mutane 40 daukar aikin sa kai don gwada kayayyakinsu. Rabin sun sami maganin alurar riga kafi yayin da sauran rabin sun sami placebo. Bege na duniya ne da kuma fatan samun rigakafin cutar coronavirus. Wannan labari ne mai kyau, a cewar likitoci, amma ya kamata a dauki wannan bayanin tare da taka tsantsan. Lallai, yawancin bayanan kimiyya sun kasance ba a san su ba. A yanzu, gwamnatin ta kasance mai rikitarwa, saboda ya zama dole a aiwatar da allura biyu, na guntuwar ka'idar kwayar cutar ta Sars-Cov-000, wanda aka raba tsakanin juna. Har ila yau, ya rage don tantance tsawon lokacin da rigakafin zai kasance. Bugu da kari, dole ne a nuna tasirin akan tsofaffi, masu rauni da kuma haɗarin haɓaka manyan nau'ikan Covid-2, tunda an gwada samfurin, ya zuwa yanzu, akan mutane masu lafiya.

A ranar 1 ga Disamba, Pfizer / BioNtech duo da dakin gwaje-gwaje na Amurka Moderna sun sanar da sakamakon farko na gwajin asibiti. Alurar rigakafin su, a cewarsu, kashi 95% da 94,5% suna aiki bi da bi. Sun yi amfani da manzo RNA, labari kuma dabarar da ba ta dace ba idan aka kwatanta da masu fafatawa da magunguna. 

Sakamakon Pfizer / BioNtech an inganta shi a cikin mujallar kimiyya, Lancet, farkon Disamba. Ba a ba da shawarar maganin alurar riga kafi na Amurka/Jamus ga mutanen da ke da alerji. Bugu da kari kuma, an fara aikin rigakafin a kasar Birtaniya, inda aka yi wa wata mata ‘yar kasar Ingila allurar farko.

Hukumar Kula da Magunguna ta Amurka ta amince da rigakafin Pfizer / BioNtech tun daga ranar 15 ga Disamba. An fara kamfen na rigakafi a Amurka. A Burtaniya, Mexico, Kanada da Saudi Arabia, yawan jama'a sun fara karba allurar farko ta BNT162b2. A cewar hukumomin lafiya na Biritaniya, ba a ba da shawarar wannan maganin ga mutanen da ke fama da rashin lafiyar alluran rigakafi, magunguna ko abinci ba. Wannan shawarar ta biyo bayan illolin da aka samu a cikin mutane biyu waɗanda ke da wani nau'i na rashin lafiyar mai tsanani.

A ranar 24 ga Disamba, da Haute Autorité de Santé ya tabbatar da wurin maganin mRNA, wanda Pfizer / BioNtech duo ya haɓaka, a cikin dabarun rigakafin a Faransa. Don haka an ba da izini a hukumance akan yankin. Alurar rigakafin cutar Covid, mai suna Comirnaty®, an fara yin allurar ne a ranar 27 ga Disamba, a cikin gidan kula da marasa lafiya, saboda makasudin shine yin allurar rigakafin a matsayin fifiko ga tsofaffi da kuma haɗarin haɓakar cututtukan cututtukan.

• Alurar rigakafin zamani

A ranar 18 ga Nuwamba, dakin gwaje-gwaje na Moderna ya ba da sanarwar cewa maganin rigakafinsa yana da tasiri 94,5%. Kamar dakin gwaje-gwaje na Pfizer, maganin alurar riga kafi daga Moderna maganin RNA ne na manzo. Ya ƙunshi allurar wani ɓangare na code ɗin ƙwayoyin cuta na Sars-Cov-2. Gwajin asibiti na mataki na 3 ya fara ne a ranar 27 ga Yuli kuma ya haɗa da mutane 30, 000% waɗanda ke cikin haɗarin haɓaka mummunan nau'ikan Covid-42. An yi waɗannan abubuwan lura kwanaki goma sha biyar bayan allurar samfur na biyu. Moderna yana da niyyar isar da allurai miliyan 19 na rigakafin “mRNA-20” da aka yi nufin Amurka kuma ta ce a shirye take ta kera tsakanin allurai miliyan 1273 da biliyan 500 a duk duniya da 1.

A ranar 8 ga Janairu, rigakafin da dakin gwaje-gwaje Moderna ya samar an ba da izini a Faransa.

• Alurar rigakafin Covid-19 Vaxzevria, wanda AstraZeneca / Oxford suka kirkira

A ranar 1 ga Fabrairu, daHukumar Kula da Magunguna ta Turai ta share maganin rigakafin da AstraZeneca / Oxford suka kirkira. Na karshen shine maganin alurar riga kafi da ke amfani da adenovirus, kwayar cuta banda Sars-Cov-2. An canza shi ta hanyar kwayoyin halitta don ya ƙunshi furotin S, wanda yake a saman coronavirus. Sabili da haka, tsarin rigakafi yana haifar da martani na kariya a yayin da yiwuwar kamuwa da cutar Sars-Cov-2.

A cikin ra'ayi, Haute Autorité de Santé yana sabunta shawarwarinta don Vaxzevria : ana ba da shawarar ga mutane masu shekaru 55 zuwa sama da kuma masu sana'a na kiwon lafiya. Bugu da kari, ungozoma da masu hada magunguna na iya yin alluran.

An dakatar da amfani da maganin AstraZeneca a Faransa na 'yan kwanaki a tsakiyar Maris. An dauki wannan matakin ne " ka'idar taka tsantsan », Bayan faruwar lokuta na thrombosis (lambobi 30 - shari'ar 1 a Faransa - a Turai don mutane miliyan 5 da aka yi wa alurar riga kafi). Hukumar Kula da Magunguna ta Turai sannan ta ba da ra'ayi game da rigakafin AstraZeneca. Ta tabbatar da cewa shi ne" lafiya kuma ba a haɗa shi da ƙara haɗarin samuwar thrombosis. An ci gaba da yin allurar wannan maganin a ranar 19 ga Maris a Faransa.

• Alurar rigakafin Janssen, Johnson & Johnson

Alurar riga kafi ce ta kwayar cuta, godiya ga adenovirus, kwayar cutar da ta bambanta da Sars-Cov-2. An canza DNA na kwayar cutar da aka yi amfani da ita ta yadda za ta samar da furotin na Spike, wanda yake a saman coronavirus. Don haka, tsarin garkuwar jiki zai iya kare kansa, a yayin kamuwa da cutar ta Covid-19, saboda za ta iya gano kwayar cutar tare da jagorantar rigakafinta a kansa. Alurar rigakafin Janssen yana da fa'idodi da yawa, saboda ana gudanar da shi a ciki kashi daya. Bugu da ƙari, ana iya adana shi a cikin wuri mai sanyi a cikin firiji na al'ada. Yana da 76% tasiri a kan mummunan nau'i na cutar. Alurar rigakafin Johnson & Johnson An haɗa shi a cikin dabarun rigakafin a Faransa, ta Haute Autorité de Santé, tun daga Maris 12. Ya kamata ya isa tsakiyar Afrilu a Faransa.

Yaya aikin alurar riga kafi ke aiki?

Alurar rigakafin DNA 

Gwajin rigakafin da aka gwada yana ɗaukar shekaru ana ƙira. A cikin lamarin kamuwa da cutar Covid-19, Cibiyar Pasteur ta tunatar da cewa ba za a samu maganin ba kafin shekarar 2021. Masu bincike a duniya suna aiki tukuru don kare jama'a daga sabon coronavirus, da aka shigo da su daga China. Suna yin gwaje-gwaje na asibiti don fahimtar wannan cuta da kuma ba da damar kula da marasa lafiya. Duniyar kimiyya ta tattara ta yadda an sami wasu alluran rigakafi daga 2020.

Cibiyar Pasteur tana aiki don ba da sakamako mai dorewa a kan sabon coronavirus. A karkashin sunan aikin "SCARD SARS-CoV-2", samfurin dabba yana fitowa don Cutar SARS-CoV-2. Na biyu, za su tantance "Immunogenicity (ikon haifar da takamaiman maganin rigakafi) da inganci (ikon kariya)". "Magungunan DNA suna da yuwuwar fa'ida akan alluran rigakafin al'ada, gami da ikon haifar da nau'ikan martanin rigakafi da yawa".

A duk duniya a yau, kusan allurai hamsin ne ake kera kuma ana tantance su. Waɗannan alluran rigakafi na sabon coronavirus a fili zai yi tasiri na ƴan watanni, idan ba ƴan shekaru ba. Labari mai dadi ga masana kimiyya shine cewa Covid-19 yana da kwanciyar hankali ta kwayoyin halitta, sabanin HIV, alal misali. 

Ana sa ran sakamakon sabbin gwajin rigakafin nan da ranar 21 ga Yuni, 2020. Cibiyar Pasteur ta kaddamar da aikin SCARD SARS-Cov-2. Masana kimiyya suna haɓaka ɗan takarar rigakafin DNA don tantance ingancin samfurin da za a yi allurar da kuma ikon samar da halayen rigakafi.

Sabunta Oktoba 6, 2020 - Inserm ya ƙaddamar da Covireivac, dandamali don nemo masu sa kai don gwada rigakafin Covid-19. Kungiyar na fatan samun masu aikin sa kai 25, wadanda suka haura shekaru 000 kuma suna cikin koshin lafiya. Kiwon Lafiyar Jama'a na Faransa da Hukumar Kula da Magunguna da Kare Kayayyakin Lafiya (ANSM) ke tallafawa aikin. Shafin ya riga ya amsa tambayoyi da yawa kuma ana samun lambar kyauta a kan 18 0805 297. Bincike a Faransa ya kasance a tsakiyar yaki da cutar tun daga farko, godiya ga nazarin magunguna da gwaje-gwaje na asibiti don samun lafiya da kuma m rigakafin. Hakanan yana ba kowa damar zama ɗan wasan kwaikwayo a kan cutar, godiya ga Covireivac. A ranar sabuntawa, babu allurar rigakafin cutar Covid-19. Koyaya, masana kimiyya a duniya sun tattara kuma suna neman ingantattun magunguna don dakatar da cutar. Alurar riga kafi ta ƙunshi allura na ƙwayoyin cuta wanda ke haifar da ƙirƙirar ƙwayoyin rigakafi a kan wakili da ake tambaya. Manufar ita ce ta haifar da halayen tsarin rigakafi na mutum, ba tare da rashin lafiya ba.

Alurar rigakafi ta RNAmessager

Ana yin alluran rigakafin gargajiya daga ƙwayar cuta mara aiki ko rauni. Suna da nufin yaƙar cututtuka da kuma rigakafin cututtuka, godiya ga ƙwayoyin rigakafi da ke samar da na'urar rigakafi, wanda zai gane ƙwayoyin cuta, don sa su zama marasa lahani. Alurar rigakafin mRNA ya bambanta. Misali, maganin da dakin gwaje-gwaje Moderna ya gwada, mai suna “MRNA-1273"Ba a yi shi daga kwayar cutar Sars-Cov-2 ba, amma daga Messenger Ribonucleic Acid (mRNA). Na karshen shine lambar kwayar halitta wacce za ta gaya wa sel yadda ake yin sunadaran, don taimakawa tsarin rigakafi ya samar da kwayoyin cutar, wanda aka yi niyya don yakar sabon coronavirus. 

Ina allurar Covid-19 zuwa yau?

An gwada alluran rigakafi guda biyu a Jamus da Amurka

Cibiyar Kiwon Lafiya ta Amurka (NIH) ta sanar a ranar 16 ga Maris, 2020, cewa ta fara gwajin asibiti na farko don gwada rigakafin cutar kanjamau. Jimlar mutane 45 masu lafiya za su ci gajiyar wannan rigakafin. Za a yi gwajin gwajin asibiti sama da makonni 6 a Seattle. Idan an yi gwajin gwajin cikin sauri, za a sayar da wannan maganin a cikin shekara guda kawai, ko ma watanni 18, idan komai ya yi kyau. A ranar 16 ga Oktoba, maganin rigakafi na Amurka daga dakin gwaje-gwaje na Johnson & Johnson ya dakatar da lokaci na 3. Lallai, ƙarshen gwajin gwaji yana da alaƙa da abin da ya faru na "cutar da ba a bayyana ba" a cikin ɗayan masu aikin sa kai. An kira wani kwamiti mai zaman kansa don kare lafiyar marasa lafiya don nazarin halin da ake ciki. 

A Jamus, ana nazarin yiwuwar rigakafin nan gaba. Cibiyar gwaje-gwajen CureVac ce ta haɓaka ta, wanda ya ƙware wajen haɓaka alluran rigakafin da ke ɗauke da kwayoyin halitta. Maimakon gabatar da nau'in kwayar cutar da ba ta da ƙarfi kamar alluran rigakafi, ta yadda jiki ke yin rigakafi, CureVac yana shigar da kwayoyin halitta kai tsaye cikin sel waɗanda za su taimaka wa jiki ya kare kansa daga cutar. Alurar rigakafin da CureVac ya samar a haƙiƙa ya ƙunshi manzo RNA (mRNA), kwayar halitta mai kama da DNA. Wannan mRNA zai ba jiki damar yin furotin da zai taimaka wa jiki yaƙar kwayar cutar da ke haifar da cutar Covid-19. Har ya zuwa yau, babu wani alluran rigakafin da CureVac ya samar da aka yi kasuwa. A gefe guda, dakin gwaje-gwajen ya sanar a farkon Oktoba cewa an fara gwajin gwajin asibiti na lokaci na 2.

Sanofi da GSK sun ƙaddamar da gwajin asibiti akan mutane

Sanofi ya kwafi halittar sunadaran da ke kan saman kawar da cutar SARS-Cov-2. Idan a GSK, zai kawo “Fasahanta don samar da alluran rigakafi don amfani da cutar. Yin amfani da adjuvant yana da mahimmanci musamman a cikin yanayi na annoba saboda zai iya rage yawan adadin furotin da ake bukata a kowane kashi, don haka yana ba da damar samar da adadi mai yawa kuma don haka yana taimakawa wajen kare yawancin marasa lafiya. mutane." Adjuvant magani ne ko magani wanda aka ƙara wa wani don haɓakawa ko haɓaka aikin sa. Saboda haka martanin rigakafi zai fi ƙarfi. Tare, watakila za su gudanar da fitar da maganin alurar riga kafi a lokacin 2021. Sanofi, wanda wani kamfani ne na harhada magunguna na Faransa, da GSK (Glaxo Smith Kline) suna aiki hannu da hannu don haɓaka maganin rigakafi. rigakafin kamuwa da cutar Covid-19, tun farkon annobar cutar. Waɗannan kamfanoni biyu suna da sabbin fasahohi. Sanofi yana ba da gudummawar antigen; wani abu ne wanda baƙon abu ne ga jiki wanda zai haifar da amsawar rigakafi.

Sabunta Satumba 3, 2020 - Maganin rigakafin Covid-19 wanda Sanofi da dakunan gwaje-gwaje na GSK suka kirkira ya ƙaddamar da wani matakin gwaji akan ɗan adam. Ana yin wannan gwajin makafi sau biyu. Wannan lokaci na gwaji na 1/2 ya shafi marasa lafiya sama da 400, waɗanda aka rarraba a cibiyoyin bincike 11 a Amurka. A cikin sanarwar manema labarai daga dakin gwaje-gwaje na Sanofi, mai kwanan wata Satumba 3, 2020, an bayyana cewa "lBinciken da ya yi daidai ya nuna aminci mai ban sha'awa da kuma immunogenicity […] Sanofi da GSK sun haɓaka masana'antar antigen da adjuvant tare da burin samar da allurai biliyan ɗaya nan da 2021".

Sabunta Disamba 1 - Ana sa ran bayyana sakamakon gwajin ga jama'a a cikin watan Disamba.

Sauran alluran rigakafi

A halin yanzu, masu neman rigakafin 9 suna cikin kashi 3 a duk duniya. Ana gwada su akan dubban masu aikin sa kai. Daga cikin wadannan alluran rigakafin a matakin karshe na gwaji, 3 Amurkawa ne, 4 na kasar Sin, 1 na Rasha, 1 kuma dan Burtaniya ne. Ana kuma gwada alluran rigakafi guda biyu a Faransa, amma suna kan matakin bincike na ƙasa. 

Vladimir Putin ya sanar da cewa ya sami maganin rigakafi coronavirus, a Rasha. Duniyar kimiyya tana da shakku, idan aka yi la'akari da saurin da aka samu. Koyaya, lokaci na 3 ya fara duka iri ɗaya, game da gwaje-gwaje. A yanzu, ba a gabatar da bayanan kimiyya ba.